Precision Anticoagulation: The Imperative Usage of DOACs for Disease-Specific Risk Stratification in MPNs and Multiple Myeloma

Eur J Haematol. 2026 Jun;116(6):949-950. doi: 10.1111/ejh.70148. Epub 2026 Feb 27.

Authors

Mehmet Baysal¹, Ahmet Emre Eşkazan²

Affiliations

¹ Division of Hematology, Department of Internal Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Türkiye.
² Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.

PMID: 41757809
DOI: 10.1111/ejh.70148

No abstract available

Keywords: JAK2; DOACs (direct Oral anticoagulants); MPN (myeloproliferative neoplasms); VTE (venous thromboembolism); multiple myeloma.

Publication types

Letter